133 related articles for article (PubMed ID: 36752470)
1. Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator.
Aktaş MK; Younis A; Saxena S; Diamond A; Ojo A; Kutyifa V; Steiner H; Steinberg JS; Zareba W; McNitt S; Polonsky B; Rosero SZ; Huang DT; Goldenberg I
JACC Clin Electrophysiol; 2023 Jul; 9(7 Pt 1):979-988. PubMed ID: 36752470
[TBL] [Abstract][Full Text] [Related]
2. QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients.
Goldenberg I; Aktas MK; Zareba W; Tsu-Chau Huang D; Rosero SZ; Younis A; McNitt S; Stockburger M; Steinberg JS; Buttar RS; Merkely B; Kutyifa V
JACC Clin Electrophysiol; 2024 Jan; 10(1):16-26. PubMed ID: 38032575
[TBL] [Abstract][Full Text] [Related]
3. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
Barsheshet A; Wang PJ; Moss AJ; Solomon SD; Al-Ahmad A; McNitt S; Foster E; Huang DT; Klein HU; Zareba W; Eldar M; Goldenberg I
J Am Coll Cardiol; 2011 Jun; 57(24):2416-23. PubMed ID: 21658562
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in the Risk of First and Recurrent Ventricular Tachyarrhythmias Among Patients Receiving an Implantable Cardioverter-Defibrillator for Primary Prevention.
Saxena S; Goldenberg I; McNitt S; Hsich E; Kutyifa V; Bragazzi NL; Polonsky B; Aktas MK; Huang DT; Rosero S; Klein H; Zareba W; Younis A
JAMA Netw Open; 2022 Jun; 5(6):e2217153. PubMed ID: 35699956
[TBL] [Abstract][Full Text] [Related]
5. Risk of Ventricular Tachyarrhythmic Events in Patients Who Improved Beyond Guidelines for a Defibrillator in MADIT-CRT.
Sherazi S; Shah F; Kutyifa V; McNitt S; Aktas MK; Polonsky B; Zareba W; Goldenberg I
JACC Clin Electrophysiol; 2019 Oct; 5(10):1172-1181. PubMed ID: 31648742
[TBL] [Abstract][Full Text] [Related]
6. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
[TBL] [Abstract][Full Text] [Related]
7. Effect of Carvedilol vs Metoprolol on Atrial and Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients.
Diamond A; Goldenberg I; Younis A; Goldenberg I; Sampath R; Kutyifa V; Chen AY; McNitt S; Polonsky B; Steinberg JS; Zareba W; Aktaş MK
JACC Clin Electrophysiol; 2023 Oct; 9(10):2122-2131. PubMed ID: 37656097
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Frequency of Ventricular Tachyarrhythmia in Men-Versus-Women in Patients with Implantable Cardioverter-Defibrillator for Primary Prevention.
Ojo A; Younis A; Saxena S; Kutyifa V; Chen AY; McNitt S; Polonsky B; Aktas MK; Huang DT; Rosero S; Vidula H; Diamond A; Sampath R; Klein H; Steiner H; Zareba W; Goldenberg I
Am J Cardiol; 2022 Aug; 176():43-50. PubMed ID: 35606170
[TBL] [Abstract][Full Text] [Related]
9. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
[TBL] [Abstract][Full Text] [Related]
10. Predictors and Risk of Ventricular Tachyarrhythmias or Death in Black and White Cardiac Patients: A MADIT-CRT Trial Substudy.
Sabbag A; Goldenberg I; Moss AJ; McNitt S; Glikson M; Biton Y; Jackson L; Polonsky B; Zareba W; Kutyifa V
JACC Clin Electrophysiol; 2016 Aug; 2(4):448-455. PubMed ID: 29759864
[TBL] [Abstract][Full Text] [Related]
11. Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study.
Kutyifa V; Daubert JP; Schuger C; Goldenberg I; Klein H; Aktas MK; McNitt S; Stockburger M; Merkely B; Zareba W; Moss AJ
Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e001965. PubMed ID: 26743237
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
[TBL] [Abstract][Full Text] [Related]
13. Survival After Implantable Cardioverter-Defibrillator Shocks.
Aktaş MK; Younis A; Zareba W; Kutyifa V; Klein H; Daubert JP; Estes M; McNitt S; Polonsky B; Goldenberg I
J Am Coll Cardiol; 2021 May; 77(20):2453-2462. PubMed ID: 34016257
[TBL] [Abstract][Full Text] [Related]
14. Death with an implantable cardioverter-defibrillator: a MADIT-II substudy.
Chernomordik F; Jons C; Klein HU; Kutyifa V; Nof E; Zareba W; Daubert JP; Greenberg H; Glikson M; Goldenberg I; Beinart R
Europace; 2019 Dec; 21(12):1843-1850. PubMed ID: 31647531
[TBL] [Abstract][Full Text] [Related]
15. CHA
Nof E; Kutyifa V; McNitt S; Goldberger J; Huang D; Aktas MK; Spencer R; Goldenberg I; Beinart R
J Am Heart Assoc; 2020 Jan; 9(1):e014353. PubMed ID: 31888428
[TBL] [Abstract][Full Text] [Related]
16. Systolic Blood Pressure and Risk for Ventricular Arrhythmia in Patients With an Implantable Cardioverter Defibrillator.
Beinart R; Goldenberg I; Younis A; McNitt S; Huang D; Aktas MK; Spencer R; Kutyifa V; Nof E
Am J Cardiol; 2021 Mar; 143():74-79. PubMed ID: 33359194
[TBL] [Abstract][Full Text] [Related]
17. Hospitalization for Heart Failure and Subsequent Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.
Younis A; Aktas MK; Lee D; Zareba W; McNitt S; Polonsky B; Kutyifa V; Rosero S; Huang D; Vidula H; Goldenberg I
JACC Clin Electrophysiol; 2021 Sep; 7(9):1099-1107. PubMed ID: 33812828
[TBL] [Abstract][Full Text] [Related]
18. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score.
Younis A; Goldberger JJ; Kutyifa V; Zareba W; Polonsky B; Klein H; Aktas MK; Huang D; Daubert J; Estes M; Cannom D; McNitt S; Stein K; Goldenberg I
Eur Heart J; 2021 May; 42(17):1676-1684. PubMed ID: 33417692
[TBL] [Abstract][Full Text] [Related]
19. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
[TBL] [Abstract][Full Text] [Related]
20. Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT.
Schuger C; Daubert JP; Zareba W; Rosero S; Yong P; McNitt S; Kutyifa V
Heart Rhythm; 2021 Mar; 18(3):399-403. PubMed ID: 33232811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
